Diabetes News and Research

Latest Diabetes News and Research

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Vitamin D2 supplementation is promising treatment for pain, depression in type 2 diabetes

Vitamin D decreases pain in women with type 2 diabetes and depression, according to a study conducted at Loyola University Chicago. These findings were presented at an Oct. 24, 2013 research conference at Loyola's Health Sciences Campus.

2 Dec 2013

Recently discovered humanin peptide could lead to powerful new treatments for diabetes

Even if the obesity trend cannot be reversed, here's hope that it's partner in crime-diabetes-might be thwarted. New research published in the December 2013 issue of The FASEB Journal shows how a recently discovered human peptide, called humanin, could lead to powerful new treatments for some people living with diabetes.

2 Dec 2013

Nocturia common in Japanese patients

Results from an outpatient-based study indicate that nocturia is common among Japanese patients, with men, the elderly, and those with hypertension at the greatest risk.

2 Dec 2013

Vitamin D status optimization could cut pneumonia cases

A large US population-based study confirms that serum 25-hydroxyvitamin D levels are associated with the risk for community-acquired pneumonia.

2 Dec 2013

New multinational survey to investigate early conversations between physicians and T2D people

Boehringer Ingelheim and Eli Lilly and Company today announced the launch of the largest multinational survey to investigate early conversations between physicians and people living with Type 2 Diabetes. The survey was developed in partnership with the International Diabetes Federation and will include more than 10,000 people with T2D and more than 6,500 treating-physicians across 26 countries worldwide

2 Dec 2013

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing, today announces that it is launching a CE/IVD labeled MID kit for Illumina MiSeq together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

2 Dec 2013

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.

2 Dec 2013

Diabetic patients can benefit by eating single large meal than several smaller meals

For patients with diabetes, it is better to eat a single large meal than several smaller meals throughout the day. This is the result of a current dietary study at Linköping University in Sweden.

28 Nov 2013

Walk-in clinics staffed by nurses can reduce health care costs, says URI professor

People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.

28 Nov 2013

Screening for genetic mutations may help identify silent carriers of adrenal Cushing's syndrome

Genetic research that will be published tomorrow in the New England Journal of Medicine suggests to Dr. André Lacroix, professor at the University of Montreal, that clinicians' understanding and treatment of a form of Cushing's syndrome affecting both adrenal glands will be fundamentally changed, and that moreover, it might be appropriate to begin screening for the genetic mutations that cause this form of the disease.

28 Nov 2013

Pre-existing diabetes in pregnant women doubles risk of death of infants

New research shows that pre-existing diabetes in pregnant women greatly increases the risk of death of their unborn fetus by around four-and-a-half times compared with pregnant women without diabetes, and also almost doubles the risk of death of infants after birth.

28 Nov 2013

Researchers create breathalyzer that may help control blood sugar

Finger pricks may soon be a thing of the past for diabetics. Researchers at Western New England University have created a breathalyzer that may help control blood sugar by measuring the amount of acetone in the breath.

27 Nov 2013

Mutation in alpha-synuclein gene causes increased vulnerability to pesticides, leading to Parkinson's

A team of researchers has brought new clarity to the picture of how gene-environmental interactions can kill nerve cells that make dopamine. Dopamine is the neurotransmitter that sends messages to the part of the brain that controls movement and coordination.

27 Nov 2013

Health benefits of eating almonds

As Americans sit down to enjoy Thanksgiving dinner, they often wish their family and friends good health and a long life. Good news! With nuts like almonds on the table, these sentiments are more than just a traditional toast.

27 Nov 2013

Advances in cardiovascular sciences to be discussed at University of Leicester

Advances in Cardiovascular Sciences are to be showcased in two public lectures at the University of Leicester.

27 Nov 2013

More than three-quarters of parents are willing to have their children participate in research

To improve healthcare for children, medical research that involves kids is a must. Yet, only five percent of parents say their children have ever participated in any type of medical research, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

27 Nov 2013

EPCs: A promising therapy for type 1 diabetes

Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted.

27 Nov 2013

Restoring helpful bacteria of the gut and intestines may treat patients with RCDI, find scientists

Scientists at the Institute for Genome Sciences at the University of Maryland School of Medicine and physicians at Sinai Hospital, Baltimore, MD, have found that restoring the normal, helpful bacteria of the gut and intestines may treat patients suffering from recurrent Clostridium difficile infections. Transplanting fecal matter of healthy donors into patients with recurrent C. difficile infection appears to restore normal bacterial composition and resolve infection.

27 Nov 2013

African Americans have double the risk of end-stage renal disease compared to white Americans

In the United States, African Americans have approximately twice the risk of end-stage renal disease compared to white Americans, despite a similar prevalence in earlier stages of chronic kidney disease. A large study co-authored by George Washington University researcher Dominic Raj, M.D., identifies factors that mediate differences in the progression of chronic kidney disease between black patients and white patients, as well as among black patients, in order to reduce the excess burden of end-stage renal disease and its complications in black patients.

27 Nov 2013

Diabetes News and Research

Latest Diabetes News and Research

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Vitamin D2 supplementation is promising treatment for pain, depression in type 2 diabetes

Recently discovered humanin peptide could lead to powerful new treatments for diabetes

Nocturia common in Japanese patients

Vitamin D status optimization could cut pneumonia cases

New multinational survey to investigate early conversations between physicians and T2D people

Multiplicom launches MID kit for Illumina MiSeq and MASTR kits for MODY, ADH and HCM

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Diabetic patients can benefit by eating single large meal than several smaller meals

Walk-in clinics staffed by nurses can reduce health care costs, says URI professor

Screening for genetic mutations may help identify silent carriers of adrenal Cushing's syndrome

Pre-existing diabetes in pregnant women doubles risk of death of infants

Researchers create breathalyzer that may help control blood sugar

Mutation in alpha-synuclein gene causes increased vulnerability to pesticides, leading to Parkinson's

Health benefits of eating almonds

Advances in cardiovascular sciences to be discussed at University of Leicester

More than three-quarters of parents are willing to have their children participate in research

EPCs: A promising therapy for type 1 diabetes

Restoring helpful bacteria of the gut and intestines may treat patients with RCDI, find scientists

African Americans have double the risk of end-stage renal disease compared to white Americans

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Diabetes News and Research

Latest Diabetes News and Research

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in